MIRA Pharmaceuticals shares are trading higher after the company announced the execution of Amendment No. 1 to its exclusive Ketamir-2 license agreement with MIRALOGX.

Benzinga Newsdesk www.benzinga.com Positive 95.5%

Neg 0% Neu 0% Pos 95.5%

Comments

No comments yet. Be the first!